Methodology

All entries for: Xeris Biopharma Holdings

March 2, 2026

Xeris Biopharma Holdings

Neutral Outlook

Chicago, IL
201-500 employees

The effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Endocrinology, Metabolic Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
Source
Source
Scroll to Top